MedTech Acquisition Corporation Warrant

YTD

ALL

Why Robinhood?

You can watch MTACW and buy or sell other stocks, ETFs, and their options commission-free!

About MTACW

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

CEO

Mary T. Szela, MBA

CEOMary T. Szela, MBA

Employees

—

Employees—

Headquarters

Westminster, Colorado

HeadquartersWestminster, Colorado

Founded

Employees

—

Employees—

MTACW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

10.12K

Average volume10.12K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$5.00

52 Week high$5.00

52 Week low

$0.4201

52 Week low$0.4201

Stock Snapshot

MedTech Acquisition Corporation Warrant(MTACW) stock is priced at $0.29.

On 2025-12-23, MedTech Acquisition Corporation Warrant(MTACW) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for MedTech Acquisition Corporation Warrant(MTACW) stock has reached 0, versus its average volume of 10.12K.

The stock's 52-week range extends from a low of $0.42 to a high of $5.00.